Go Deep
Adicet Bio, Inc.
Adicet Bio, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 25,103 | -0.9 | 0.81 | 0.11 | 865.31 |
| Oct 2026 | 21,776 | -0.6 | 0.51 | 0.11 | 625.15 |
| Oct 2026 | 21,776 | -0.6 | 0.51 | 0.11 | 625.15 |
| Oct 2026 | 21,786 | -0.6 | 0.50 | 0.11 | 622.27 |
| Oct 2026 | 21,607 | -0.6 | 0.49 | 0.11 | 602.61 |
| Oct 2026 | 21,607 | -0.6 | 0.49 | 0.11 | 602.61 |
| Oct 2026 | 21,630 | -0.6 | 0.48 | 0.11 | 596.59 |
| Oct 2026 | 21,774 | -0.6 | 0.45 | 0.11 | 554.12 |
| Oct 2026 | 22,066 | -0.5 | 0.44 | 0.11 | 542.80 |
| Oct 2026 | 22,081 | -0.5 | 0.43 | 0.11 | 529.45 |
| Oct 2026 | 22,237 | -0.5 | 0.40 | 0.11 | 486.64 |
| Oct 2026 | 22,310 | -0.5 | 0.38 | 0.11 | 464.29 |
| Oct 2026 | 22,227 | -0.5 | 0.40 | 0.11 | 488.10 |
| Oct 2026 | 22,410 | -0.4 | 0.36 | 0.11 | 432.85 |
| Oct 2026 | 22,385 | -0.4 | 0.35 | 0.11 | 429.52 |
| Oct 2026 | 22,388 | -0.4 | 0.35 | 0.11 | 428.57 |
| Oct 2026 | 22,262 | -0.4 | 0.35 | 0.11 | 424.67 |
| Oct 2026 | 22,340 | -0.4 | 0.33 | 0.11 | 403.99 |
| Oct 2026 | 22,448 | -0.4 | 0.31 | 0.11 | 378.18 |
Adicet Bio, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -21,358,000.0 | -20,244,000.0 | -30,516,000.0 | -26,856,000.0 |
| EPS | -2.0 | -1.9 | -2.9 | -4.6 |
Adicet Bio, Inc. Revenue & Profit: Last 4 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 24,990,000.0 |
| Net Profit | -116,803,000.0 | -117,122,000.0 | -142,658,000.0 | -69,790,000.0 |
| EPS | -16.9 | -21.3 | -53.0 | -27.2 |
Adicet Bio, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 192,355,000.0 | 220,219,000.0 | 207,295,000.0 | 330,690,000.0 | — |
| Total Liabilities | 33,145,000.0 | 33,610,000.0 | 37,120,000.0 | 38,352,000.0 | — |
| Total Equity | 159,210,000.0 | 186,609,000.0 | 170,175,000.0 | 292,338,000.0 | — |
Owes vs Owns
Adicet Bio, Inc. owed $0.19 for every $1 it owned in Jun 2026, up from $0.12 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.19× | 0.17× | 0.15× | 0.18× | 0.12× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Adicet Bio, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 82.4%Fixed assets (tangible) 14.8%Other assets 2.6%
How it's funded — Dec 2025
Short-term debt 1.7%Long-term debt 6.0%Payables 2.5%Other liabilities 7.1%Shareholders' equity 82.8%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 158.5 | 176.3 | 159.7 | 257.7 |
| Receivables | 0.3 | 0.1 | 0.0 | 0.4 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 28.5 | 36.8 | 44.2 | 49.0 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 19.5 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 5.0 | 7.1 | 3.4 | 4.2 |
| Liabilities & equity | ||||
| Short-term debt | 3.2 | 3.1 | 3.2 | 2.5 |
| Long-term debt | 11.6 | 14.1 | 17.7 | 18.5 |
| Payables | 4.7 | 4.8 | 2.6 | 4.4 |
| Other liabilities | 13.7 | 11.5 | 13.6 | 12.9 |
| Shareholders' equity | 159.2 | 186.6 | 170.2 | 292.3 |
| Net tangible assets | 159.2 | 186.6 | 170.2 | 272.9 |
Adicet Bio, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -95,246,000.0 | -92,378,000.0 | -93,717,000.0 | -44,765,000.0 | — |
| Investing Activities | 2,393,000.0 | -119,242,000.0 | -4,464,000.0 | -16,782,000.0 | — |
| Financing Activities | 75,245,000.0 | 111,307,000.0 | 236,000.0 | 41,509,000.0 | — |